Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01983813 · ClinicalTrials.gov registry record · NA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
A NA study, sponsored by Korey Kennelty.
- Completed
- Registry status
- NA
- Development phase
- 302
- Enrollment target
NCT01983813: Completed NA study, sponsored by Korey Kennelty.
NCT01983813 is a NA study that has completed, run by Korey Kennelty. The registered enrollment target is 302 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01983813, a NA study, has completed, sponsored by Korey Kennelty.
- COMPLETED
- Registry status
- NA
- Development phase
- 302 participants
- Enrollment target
Study Summary
The trial will examine whether a centralized Prevention Health \& Cardiovascular Risk Service (PHCVRS) run by clinical pharmacists at the University of Iowa can be implemented in primary care offices and whether it can improve the care delivered to patients at risk for developing cardiovascular disease.
Primary Outcome
The primary outcome measure was adherence to the GA criteria as a surrogate for quality of care because each subject had varying gaps in guideline-concordant care, depending on their specific cardiovascular conditions and preventative care needs.
Interventions
- OTHER PHCVRS Intervention
- OTHER Personal Health Record
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2014-03-19 |
| Est. Completion | 2018-04 |
| Phase | NA |
What the finished NCT01983813 record still lists
NCT01983813 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which PHCVRS Intervention is the first listed.
NCT01983813 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01983813 about?
NCT01983813 is a clinical study titled "Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care". The trial will examine whether a centralized Prevention Health \& Cardiovascular Risk Service (PHCVRS) run by clinical pharmacists at the University of Iowa can be implemented in primary care offices and whether it can improve the care delivered to patients at risk for developing cardiovascular dise...
What is the current status of trial NCT01983813?
This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2014-03-19. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01983813?
The interventions under investigation include: PHCVRS Intervention (OTHER), Personal Health Record (OTHER).
Who is sponsoring clinical trial NCT01983813?
This trial is sponsored by Korey Kennelty, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01983813's enrollment target sits among peer trials
302 330th of 2000 higher than 1,671 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI